The clinical characteristics of NSCLC patients that are positive for EML4-ALK variants are similar to those of who harbor activating mutations in the EGFR gene: both groups of patients tend to manifest an adenocarcinoma histological subtype and to be non or light smokers (9). This evidence concerns the gene ALK and non-small cell lung carcinoma.